Thomas Borcholte
Directeur Général chez Wilex, Inc.
Profil
Thomas Borcholte is currently the Chairman-Supervisory Board at DETEK AG and the Executive Director & Managing Director at Wilex, Inc. He previously worked as a Non-Executive Director at NextGen Group Plc and NextGen Sciences Ltd., Director-Sales & Marketing at Topotarget A, Principal at Biogen MA, Inc., Wellcome Plc, and GlaxoWellcome, and as the Chief Business Officer at Heidelberg Pharma AG from 2007 to 2013.
He also served as the Chief Sales & Marketing Officer at TopoTarget UK Ltd.
Dr. Borcholte received his undergraduate and doctorate degrees from the University of Hannover.
Postes actifs de Thomas Borcholte
| Sociétés | Poste | Début |
|---|---|---|
Detek AG
 Detek AG Miscellaneous Commercial ServicesCommercial Services DETEK AG is a German economic investigation company founded in 1978. The private company is based in Hannover, Germany. The company provides services in various scenarios where economic investigators are needed. The text in the company's description is in both German and English, indicating that they may operate in both countries or provide services to clients who speak either language. | Président | - |
Wilex, Inc.
 Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Directeur Général | - |
Anciens postes connus de Thomas Borcholte
| Sociétés | Poste | Fin |
|---|---|---|
| HEIDELBERG PHARMA AG | Corporate Officer/Principal | 31/12/2013 |
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Corporate Officer/Principal | - |
NextGen Sciences Ltd.
 NextGen Sciences Ltd. BiotechnologyHealth Technology NextGen Sciences Ltd. provides technologies and reagents for molecular biology and protein research. Its advanced products automate and simplify complex research techniques, saving time and resources, improving results, and accelerating discovery. The company was founded on January 28, 2000 by Kevin Auton and David Wigley and is headquartered in Huntingdon, the United Kingdom. | Directeur/Membre du Conseil | - |
Formation de Thomas Borcholte
| University of Hannover | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEIDELBERG PHARMA AG | Health Technology |
| Entreprise privées | 9 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
NextGen Group Plc
 NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | Commercial Services |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Commercial Services |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
NextGen Sciences Ltd.
NextGen Sciences Ltd. BiotechnologyHealth Technology NextGen Sciences Ltd. provides technologies and reagents for molecular biology and protein research. Its advanced products automate and simplify complex research techniques, saving time and resources, improving results, and accelerating discovery. The company was founded on January 28, 2000 by Kevin Auton and David Wigley and is headquartered in Huntingdon, the United Kingdom. | Health Technology |
Wilex, Inc.
Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Health Services |
Detek AG
Detek AG Miscellaneous Commercial ServicesCommercial Services DETEK AG is a German economic investigation company founded in 1978. The private company is based in Hannover, Germany. The company provides services in various scenarios where economic investigators are needed. The text in the company's description is in both German and English, indicating that they may operate in both countries or provide services to clients who speak either language. | Commercial Services |